title: Efalizumab-induced immune thrombocytopenia during retreatment.
authors.forename: Maria Concetta
authors.initials: MC
authors.lastname: Fargnoli
authors.forename: Antonio
authors.initials: A
authors.lastname: Tabilio
authors.forename: Gino
authors.initials: G
authors.lastname: Coletti
authors.forename: Ketty
authors.initials: K
authors.lastname: Peris
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008297:Male; D010976:Platelet Count; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology*; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab